Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions
- PMID: 31718900
- DOI: 10.1016/j.vaccine.2019.10.098
Improvement of a recombinant avian avulavirus serotype 10 vectored vaccine by the addition of untranslated regions
Abstract
Background: We have previously developed a recombinant avian avulavirus serotype 10 (rAAvV-10/HA) expressing the hemagglutinin (HA) gene of a highly pathogenic avian influenza virus (HPAIV) as an emergency vaccine for poultry. rAAvV-10/HA can overcome the activity of the anti-AAvV-1 (Newcastle disease virus) antibody acquired by commercial chickens upon routine vaccination. Most chickens do not have the anti-AAvV-10 antibody, which could interfere with the vaccine efficacy. However, the vaccine efficacy of rAAvV-10/HA is not satisfactory in chickens even though it affords protection against an HPAIV challenge. In the present study, we improved the rAAvV-10/HA vaccine by enhancing the expression of the exogenous HA protein.
Methods: The 5' and 3' untranslated regions (UTR) of each AAvV-10 gene were flanked with the exogenous HA gene cassette to modify rAAvV-10/HA, yielding different rAAv10-UTRs. As a control, rAAv10-nonUTR that did not contain any UTRs was generated. The effects of UTRs on mRNA transcription, HA protein expression, and vaccine efficacy were then examined using embryonated chicken eggs and white leghorn chickens.
Results: The proportion of the HA gene mRNA among the vector-derived mRNAs (1.55-1.84-fold increase vs. the control) and HA protein levels (148-1151-fold increase vs. the control) in cells infected with rAAv10-UTRs were higher than in those infected with rAAv10-nonUTR. In vivo, vaccination of chickens with rAAv10-UTRs resulted in 100% protection against an HPAIV challenge. No chickens vaccinated with rAAv10-NP-UTR, rAAv10-F-UTR, or rAAv10-HN-UTR shed the virus in the throat and cloaca swabs. By contrast, rAAv10-nonUTR vaccination offered 70% protection, with 50% of chickens shedding the virus in the cloaca or throat swabs after the challenge. We conclude that the AAvV-10 UTRs can enhance the expression of the exogenous HA gene, resulting in improved efficacy of the rAAvV-10/HA vector vaccine. This improvement aids in the protection of flocks worldwide from the highly pathogenic avian influenza.
Keywords: Avian avulavirus (AAvV); Emergency vaccination; Highly pathogenic avian influenza (HPAI); Untranslated region (UTR); Vaccine vector.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Protection of Chickens with Maternal Immunity Against Avian Influenza Virus (AIV) by Vaccination with a Novel Recombinant Newcastle Disease Virus Vector.Avian Dis. 2020 Dec 1;64(4):427-436. doi: 10.1637/aviandiseases-D-20-00014. Avian Dis. 2020. PMID: 33347549
-
A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge.Sci Rep. 2020 Feb 10;10(1):2221. doi: 10.1038/s41598-020-59124-x. Sci Rep. 2020. PMID: 32042001 Free PMC article.
-
A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.Virology. 2017 Mar;503:31-36. doi: 10.1016/j.virol.2017.01.006. Epub 2017 Jan 19. Virology. 2017. PMID: 28110247
-
Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.Viruses. 2019 Mar 26;11(3):300. doi: 10.3390/v11030300. Viruses. 2019. PMID: 30917500 Free PMC article. Review.
-
Development and use of fowlpox vectored vaccines for avian influenza.Ann N Y Acad Sci. 2006 Oct;1081:193-201. doi: 10.1196/annals.1373.023. Ann N Y Acad Sci. 2006. PMID: 17135511 Review.
Cited by
-
"Antigen Camouflage and Decoy" Strategy to Overcome Interference From Maternally Derived Antibody With Newcastle Disease Virus-Vectored Vaccines: More Than a Simple Combination.Front Microbiol. 2021 Aug 27;12:735250. doi: 10.3389/fmicb.2021.735250. eCollection 2021. Front Microbiol. 2021. PMID: 34512613 Free PMC article. No abstract available.
-
Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken.Viruses. 2022 Apr 28;14(5):918. doi: 10.3390/v14050918. Viruses. 2022. PMID: 35632659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous